Tonix Pharmaceuticals Holding CEO Seth Lederman's 2023 pay falls 55% to $2.1M

Tonix Pharmaceuticals Holding reports 2023 executive compensation

By ExecPay News

Published: April 15, 2024

Tonix Pharmaceuticals Holding reported fiscal year 2023 executive compensation information on April 15, 2024.
In 2023, four executives at Tonix Pharmaceuticals Holding received on average a compensation package of $1.2M, a 44% decrease compared to previous year.
Average pay of disclosed executives at Tonix Pharmaceuticals Holding
Seth Lederman, Chief Executive Officer, received $2.1M in total, which decreased by 55% compared to 2022. 67% of Lederman's compensation, or $1.4M, was in option awards. Lederman also received $675K in salary.
Gregory Sullivan, Chief Medical Officer, received a compensation package of $952K, which decreased by 36% compared to previous year. 50% of the compensation package, or $480K, was in salary.
Jessica Morris, Chief Operations Officer, earned $929K in 2023, a 33% decrease compared to previous year.
Bradley Saenger, Chief Financial Officer, received $905K in 2023, which decreases by 27% compared to 2022.

Related executives

Seth Lederman

Tonix Pharmaceuticals Holding

Chief Executive Officer

Jessica Morris

Tonix Pharmaceuticals Holding

Chief Operations Officer

Bradley Saenger

Tonix Pharmaceuticals Holding

Chief Financial Officer

Gregory Sullivan

Tonix Pharmaceuticals Holding

Chief Medical Officer

You may also like

Source: SEC filing on April 15, 2024.